Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19

NCT04632706 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: Ivermectin
DRUG: Placebo

Sponsor

MedinCell S.A